| CASE REPORT |
|
| Year : 2020 | Volume
: 9
| Issue : 4 | Page : 289-291 |
|
|
Use of high-dose octreotide in the treatment of congenital chylothorax
Mohammad Abdulaziz Alhasoon
Department of Pediatrics, Unaizah College of Medicine and Medical Sciences, Qassim University, Buraydah, Kingdom of Saudi Arabia
Correspondence Address:
Dr. Mohammad Abdulaziz Alhasoon
Department of Pediatrics, Unaizah College of Medicine and Medical Sciences, Qassim University, Buraydah
Kingdom of Saudi Arabia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jcn.JCN_38_20
|
|
|
The report provides a critical examination of the use of octreotide at a dosage of 20 μg/kg/h in the treatment of congenital chylothorax. The case analysis recounts a recent application of high-dosage octreotide in the treatment of a neonatal patient who failed to respond to a lower dosage of octreotide. In this case, the patient responded effectively to octreotide at 20 μg/kg/h and was subsequently discharged without any side effects. This case is compared with similar cases published in recent literature to advance the clinical analysis of a potential application of high-dose octreotide in the treatment of congenital chylothorax when lower dosages fail to produce results.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
